We recently reported that genetic tumor PDL1 depletion reduced homologous recombination DNA damage repair, increased DNA damage, and improved tumor PARP inhibitor (PARPi) and gemcitabine sensitivity [14], which expands the current knowledge of tumor-intrinsic PDL1 functions in treatment resistance. Here, CD274 is linked to neoplasm.